| 12173051 |
Bispecific molecules comprising an HIV-1 envelope targeting arm |
Barton F. Haynes, Guido Ferrari, Leslie S. Johnson, Chia-Ying Kao Lam, Julia A. Sung +3 more |
2024-12-24 |
|
| 11858991 |
LAG-3-binding molecules and methods of use thereof |
Ross La Motte-Mohs, Kalpana Shah, Douglas H. Smith, Leslie S. Johnson, Paul A. Moore +1 more |
2024-01-02 |
$11,568,000 |
| 11840571 |
Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4 |
Leslie S. Johnson, Gurunadh Reddy Chichili, Kalpana Shah, Ross La Motte-Mohs, Paul A. Moore +1 more |
2023-12-12 |
$10,306,000 |
| 11787871 |
Methods for the treatment of disease using immunoglobulins having fc regions with altered affinities for FcgammaRactivating and FegammaRinhibiting |
Jeffrey B. Stavenhagen |
2023-10-17 |
$6,056,000 |
| 11639386 |
Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof |
Leslie S. Johnson, Ezio Bonvini, Chia-Ying Kao Lam, Paul A. Moore, Liqin Liu |
2023-05-02 |
$10,664,000 |
| 11623959 |
PD-1-binding molecules and methods of use thereof |
Kalpana Shah, Douglas H. Smith, Ross La Motte-Mohs, Leslie S. Johnson, Paul A. Moore +1 more |
2023-04-11 |
$9,665,000 |
| 11421031 |
Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof |
Leslie S. Johnson, Chia-Ying Kao Lam, Liqin Liu, Jeffrey Lee Nordstrom, Barton F. Haynes +1 more |
2022-08-23 |
$4,532,000 |
| 11174315 |
Combination therapy for the treatment of cancer |
James Vasselli, Jon M. Wigginton, Ezio Bonvini |
2021-11-16 |
$17,746,000 |
| 11098119 |
Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof |
Ezio Bonvini, Leslie S. Johnson, Kalpana Shah, Ross La Motte-Mohs, Paul A. Moore |
2021-08-24 |
$9,808,000 |
| 11078279 |
Combination therapy for the treatment of cancer |
Jon M. Wigginton, Naimish Bharat Pandya, Robert Joseph Lechleider, Ezio Bonvini |
2021-08-03 |
$21,594,000 |
| 11072653 |
LAG-3-binding molecules and methods of use thereof |
Ross La Motte-Mohs, Kalpana Shah, Douglas H. Smith, Leslie S. Johnson, Paul A. Moore +1 more |
2021-07-27 |
$22,267,000 |
| 10954301 |
Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereof |
Leslie S. Johnson, Gurunadh Reddy Chichili, Kalpana Shah, Ross La Motte-Mohs, Paul A. Moore +1 more |
2021-03-23 |
$115,266,000 |
| 10730947 |
Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof |
Leslie S. Johnson, Chia-Ying Kao Lam, Liqin Liu, Jeffrey Lee Nordstrom, Barton F. Haynes +1 more |
2020-08-04 |
$42,462,000 |
| 10717778 |
Bispecific molecules comprising an HIV-1 envelope targeting arm |
Barton F. Haynes, Guido Ferrari, Leslie S. Johnson, Chia-Ying Kao Lam, Julia A. Sung +3 more |
2020-07-21 |
|
| 10711069 |
Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting |
Jeffrey B. Stavenhagen |
2020-07-14 |
$88,727,000 |
| 10633443 |
Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof |
Leslie S. Johnson, Ezio Bonvini, Chia-Ying Kao Lam, Paul A. Moore, Liqin Liu |
2020-04-28 |
$2,718,000 |
| 10577422 |
PD-1-binding molecules and methods of use thereof |
Kalpana Shah, Douglas H. Smith, Ross La Motte-Mohs, Leslie S. Johnson, Paul A. Moore +1 more |
2020-03-03 |
$5,206,000 |
| 10160806 |
Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof |
Ezio Bonvini, Leslie S. Johnson, Kalpana Shah, Ross La Motte-Mohs, Paul A. Moore |
2018-12-25 |
|
| 9908938 |
Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof |
Leslie S. Johnson, Chia-Ying Kao Lam, Liqin Liu, Jeffrey Lee Nordstrom, Barton F. Haynes +1 more |
2018-03-06 |
$12,576,000 |
| 9708408 |
Methods for the treatment of disease using immunoglobulins having Fc Regions with altered affinities for FcγRactivating and FcγRinhibiting |
Jeffrey B. Stavenhagen |
2017-07-18 |
$8,316,000 |
| 9487587 |
Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof |
— |
2016-11-08 |
$13,181,000 |
| 9056906 |
Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity |
Ronald Wilder, Ezio Bonvini, Leslie S. Johnson |
2015-06-16 |
$14,937,000 |
| 9049782 |
Mobile device case with retractor reel assembly for user-provided headphones |
David Conroy |
2015-06-02 |
|
| 8968730 |
FcγRIIB specific antibodies and methods of use thereof |
Maria Concetta Veri, Nadine Tuaillon |
2015-03-03 |
$15,499,000 |
| 8946387 |
FcγRIIB specific antibodies and methods of use thereof |
Maria Concetta Veri, Nadine Tuaillon, Ezio Bonvini |
2015-02-03 |
$13,478,000 |